Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study (Q43074672)
Jump to navigation
Jump to search
scientific article published on 16 July 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study |
scientific article published on 16 July 2009 |
Statements
1 reference
Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study (English)
1 reference
J Rosenstock
1 reference
V Fonseca
1 reference
J B McGill
1 reference
M Riddle
1 reference
J P Hallé
1 reference
I Hramiak
1 reference
P Johnston
1 reference
M Davis
1 reference
Identifiers
1 reference